Net income increased 27.0%
Net income changed +27.0% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed +27.0% from the comparable as-filed period.
Research & development changed -8.5% from the comparable as-filed period.
Selling, general & administrative changed +5.3% from the comparable as-filed period.
Cash & equivalents changed +1.1% from the comparable as-filed period.
Debt changed +1.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross margin changed +17 basis points from the comparable as-filed period.
Gross profit changed +2.4% from the comparable as-filed period.
Inventory changed +3.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating income changed +2.1% from the comparable as-filed period.
Operating margin changed +3 basis points from the comparable as-filed period.
Revenue changed +1.7% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.